HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?

AbstractOBJECTIVES:
Heparin rebound, the reappearance of anticoagulant activity after adequate neutralization with protamine, is thought to contribute to excessive postoperative bleeding after cardiac surgery. We have previously demonstrated that a significant amount of heparin is bound nonspecifically to plasma proteins and is incompletely neutralized by protamine. The aim of this study was to investigate whether clinically important bleeding attributable to heparin rebound can be eliminated by infusion of small amounts of additional protamine for 6 hours postoperatively and whether this treatment can reduce mediastinal blood loss.
METHODS:
Three hundred patients undergoing elective cardiac surgery were randomized to receive either a continuous infusion of protamine sulphate (25 mg/h for 6 hours) postoperatively or saline placebo. Serial blood samples were obtained to measure thrombin clotting time and anti-factor Xa activity. Heparin bound nonspecifically to plasma proteins was measured after displacement with a chemically altered heparin with low affinity to antithrombin. Mediastinal blood loss and transfusion requirements were recorded.
RESULTS:
Heparin rebound was demonstrated in every patient in the placebo group as reflected by increased thrombin clotting time, anti-factor Xa activity, and protein-bound heparin between 1 and 6 hours after surgery. In contrast, heparin rebound was eliminated in the protamine infusion group. The thrombin clotting time was normalized and both heparin concentration and protein-bound heparin were almost undetectable (P <.001). There was a modest 13% reduction in postoperative bleeding but this did not reduce blood transfusions. No adverse events were attributable to the extra protamine.
CONCLUSIONS:
Postoperative protamine infusion was able to almost totally abolish heparin rebound. In the context of this study, protamine infusion resulted in reduced postoperative bleeding but the magnitude was insufficient to alter transfusion requirements.
AuthorsKevin H T Teoh, Edward Young, Mary Helen Blackall, Robin S Roberts, Jack Hirsh
JournalThe Journal of thoracic and cardiovascular surgery (J Thorac Cardiovasc Surg) Vol. 128 Issue 2 Pg. 211-9 (Aug 2004) ISSN: 0022-5223 [Print] United States
PMID15282457 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Blood Proteins
  • Heparin Antagonists
  • Protamines
  • Heparin
Topics
  • Anticoagulants (adverse effects, metabolism)
  • Blood Loss, Surgical (statistics & numerical data)
  • Blood Proteins (metabolism)
  • Blood Transfusion (statistics & numerical data)
  • Cardiopulmonary Bypass
  • Double-Blind Method
  • Female
  • Heparin (adverse effects, metabolism)
  • Heparin Antagonists (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Care
  • Protamines (therapeutic use)
  • Protein Binding
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: